Comparative Bioavailability of XS004 (Dasatinib) Formulation G and SPRYCEL® (Dasatinib) in Healthy, Adult Subjects Under Fasting Conditions

Clinical trial NCT05439408 · COMPLETED

Trial details

NCT number: NCT05439408
Sponsor: Xspray Pharma AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Biological Availability

Start date: 2021-06-07
Primary completion: 2021-06-25
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.